RESEARCH PAPER
Fibrinogen as an acute phase protein after total hip replacement
More details
Hide details
1
Klinika Traumatologii i Ortopedii CSK MON WOIM w Warszawie; kierownik: prof. dr hab. n. med. Krzysztof Kwiatkowski
2
Klinika Chorób Wewnętrznych i Hematologii CSK MON WIM w Warszawie; kierownik: prof. dr hab. n. med. Piotr Rzepecki
3
Klinika Anestezjologii i Intensywnej Terapii CSK MON WIM w Warszawie; kierownik: dr n. med. Andrzej Truszczyński
Submission date: 2018-08-16
Publication date: 2018-12-10
LW 2019;97(1):26-29
KEYWORDS
ABSTRACT
The aim of this study was to analyze the changes in fibrinogen concentration in patients who underwent total hip arthroplasty. In this prospective study 30 patients (18 females) with a mean age of 70 years (range, 45–86 years) suffering from idiopathic hip osteoarthritis and qualified for elective surgery were analyzed. Fibrinogen levels were established immunoenzymatically prior to the surgery, 6 hours after the procedure, and on days 2, 4 and 6 after the surgery. None of the patients demonstrated any symptoms of venous thromboembolism during hospital stay. The mean fibrinogen concentration equaled 366 mg/dl before the surgery, dropped to 311 mg/dl 6 hours after the procedure, then increased up to 827 mg/dl on POD 4. Increased baseline fibrinogen values (>400 mg/dl) were found in 20% of patients. After elective total hip arthroplasty, fibrinogen acts like an acute phase protein.
CONFLICT OF INTEREST
No conflicts of interest were declared.